Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Guiyang Xintian Pharmaceutical

Ping An Securities: Give Xintian Pharmaceutical an Overweight Rating_Stock News_Market Gold Online

  • Post date May 16, 2022 — 08:37 Post Lock Login to View

Read More

Xintian Pharmaceutical (002873): Participate in the 2021 Annual Performance Briefing Meeting of Listed Companies in Guizhou and Investor Collective Reception Day Activities- CFi.CN Zhongcai.com

  • Post date May 5, 2022 — 22:50 Post Lock Login to View

Read More

Sector Changes New Crown Treatment Drug Sales Hot New Crown Drug Concept Stocks Strengthened_Stock News_Market_Zhongjin Online

  • Post date May 5, 2022 — 12:19 Post Lock Login to View

Read More

Pharmaceutical and Biological Industry Weekly Report: Internal and external disturbances in pharmaceutical stock prices need to continue to select pharmaceutical stocks for layout – yqqlm

  • Post date April 25, 2022 — 10:45 Post Lock Login to View

Read More

Clay Innovation Healthcare Shares Down 3.74% Net Worth

  • Post date April 22, 2022 — 07:10 Post Lock Login to View

Read More

Chinese medicine can make a difference! Zuoli Pharmaceutical's performance has continuously increased significantly, and R&D investment needs to be increased.

  • Post date April 21, 2022 — 10:07 Post Lock Login to View

Read More

81 shares were surveyed by institutions and Tofflon received the most attention

  • Post date April 15, 2022 — 00:42 Post Lock Login to View

Read More

[Exploration of the Air outlet · Traditional Chinese Medicine] The curative effect is recognized! WHO encourages member states to absorb traditional Chinese medicine and Chinese medicine to go overseas or go further

  • Post date April 6, 2022 — 12:52 Post Lock Login to View

Read More

Orient Fortune Securities gave Xintian Pharmaceutical an overweight rating. Comments on the 2021 annual report: Forming a multi-gradient series of products and vigorously deploying the OTC market has achieved results.

  • Post date April 5, 2022 — 09:59 Post Lock Login to View

Read More

Orient Fortune Securities: Give Xintian Pharmaceutical an Overweight Rating_Stock News_Market Gold Online

  • Post date April 5, 2022 — 09:57 Post Lock Login to View

Read More

Orient Fortune Securities: Give Xintian Pharmaceutical an Overweight Rating-News Channel-Hexun.com

  • Post date April 5, 2022 — 09:56 Post Lock Login to View

Read More

Focus on research! 467 institutions are eyeing the leader of lithium mines, and the production capacity will account for one-third of the world in three years. The leader of slicers indicates the general development trend of the industry – yqqlm

  • Post date April 3, 2022 — 07:41 Post Lock Login to View

Read More

Focus on research! More than 400 institutions are eyeing the leader of lithium mines, and the production capacity in three years will account for one-third of the world's total. The leader of slicers indicates the general development trend of the industry, and the high-growth stocks that institutions are highly concerned about are released

  • Post date April 3, 2022 — 07:29 Post Lock Login to View

Read More

  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.